Innovent Biologics, Inc. (1801.HK) - Stock Prices, Stock Peers & Analysis

Home
1801.HK

Company Name	Innovent Biologics, Inc.
Symbol	1801.HK
Currency	HKD
Price	43.15
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	70,303,432,000
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	28.3 - 49.8
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. De-Chao Yu Ph.D.
Website	https://www.innoventbio.com

An error occurred while fetching data.

About Innovent Biologics, Inc.

Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of